Acne Clinical Research Studies

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Belleair Research Center

837

mi

from 43215

Pinellas Park, FL

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Progressive Clinical Research

1137

mi

from 43215

San Antonio, TX

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Gary M. Petrus, MD, PA

623

mi

from 43215

Little Rock, AR

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Center for Dermatology & Laser Surgery

2041

mi

from 43215

Sacramento, CA

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Rady Children's Hospital - Pediatric and Adolescent Dermatology

1947

mi

from 43215

San Diego, CA

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Southern California Dermatology, Inc.

1960

mi

from 43215

Santa Ana, CA

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Clinical Science Institute

1984

mi

from 43215

Santa Monica, CA

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Memorial Research Medical Clinic dba / Orange County Research Center

1957

mi

from 43215

Tustin, CA

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Horizons Clinical Research Center, LLC

1159

mi

from 43215

Denver, CO

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Study Protocol, Inc.

943

mi

from 43215

Boynton Beach, FL

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Tory Sullivan MD PA

983

mi

from 43215

North Miami Beach, FL

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Meridien Research

842

mi

from 43215

Saint Petersburg, FL

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

Moore Clinical Research, Inc.

831

mi

from 43215

Tampa, FL

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

An Open-Label, Long-Term Extension Study to Evaluate the Safety of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice-Daily in Subjects With Acne Vulgaris

Status: Enrolling
Updated: 12/31/1969

MedaPhase, Inc.

465

mi

from 43215

Newnan, GA

Clinical Research Trials Archive – Closed Trials

Zip code

Condition

We've found

1,860

archived clinical trials in

Acne

Clinical Research Trials Archive – Closed Trials

Zip code

Condition

We've found 1,860 archived clinical trials in Acne

Select your condition

Common Conditions

All Conditions

We've found

1,860

archived clinical trials in

Acne